银屑病皮肤及肠道微生态研究进展

doi:10.3760/cma.j.issn.0412-4030.2019.02.019

摘要/Abstract

摘要： 【摘要】银屑病是一种主要表现为红斑、鳞屑的常见的慢性非感染性炎症性皮肤病。该病可被认为是一种系统性疾病，研究证实其与包括心血管疾病、肥胖、2型糖尿病，血脂异常、非酒精性脂肪肝、焦虑症、抑郁症和炎症性肠病等多种疾病存在联系。其发生发展与免疫反应密切相关，其中炎细胞浸润激活导致的T淋巴细胞免疫功能紊乱被证明是银屑病发病的关键环节。T淋巴细胞活化增殖，并在局部微环境中所存在的不同种类细胞因子调控下分化成不同亚群，从而参与银屑病发病。近年来研究者发现，局部微生物也在这一过程中发挥重要作用，本文就目前皮肤及肠道微生物在银屑病中的研究进展展开综述。

关键词: 银屑病；肠；微生物群落；免疫 ,

Abstract: 【Abstract】 Psoriasis is a chronic, non-infective inflammatory dermatosis characterized by erythemas covered with scales. Psoriasis is considered as a systemic disease, and several studies have confirmed that it is associated with many other diseases, such as cardiovascular diseases, obesity, diabetes mellitus typeⅡ, dyslipidemia, nonalcoholic fatty liver disease, anxiety disorder, depression and inflammatory bowel disease. The occurrence and development of psoriasis is closely related to the immune response, and the immune dysfunction of T lymphocytes induced by the infiltration and activation of inflammatory cells has been confirmed as the key step in the pathogenesis of psoriasis. Various kinds of cytokines in the local microenvironment can promote the activation and proliferation of T lymphocytes, and regulate the differentiation of T lymphocytes into different subsets, which take an important part in the occurrence of psoriasis. In recent years, researchers have found that local microbes also play an important role in this process. Thus, this review summarizes the progress in the roles of human skin and gut microbiota in psoriasis.

Key words: Psoriasis, Intestines, Microbial consortia, Immunity

中图分类号:

彭琛陈文娟于宁高芸璐易雪梅丁杨峰. 银屑病皮肤及肠道微生态研究进展[J]. 中华皮肤科杂志, 2019, 52(2): 135-137.

Peng Chen, Chen Wenjuan, Yu Ning, Gao Yunlu, Yi Xuemei, Ding Yangfeng. The progress of relationship between psoriasis and microecology of skin and intestine[J]. Chinese Journal of Dermatology, 2019, 52(2): 135-137.

参考文献 29

［1］	Giunta A, Ventura A, Chimenti MS, et al. Spotlight on ixekizumab for the treatment of moderate⁃to⁃severe plaque psoriasis: design, development, and use in therapy［J］. Drug Des Devel Ther, 2017,11:1643⁃1651. doi: 10.2147/DDDT.S92128.
［2］	Frieder J, Kivelevitch D, Menter A. Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature［J］. Ther Deliv, 2017,8（9）:737⁃746. doi: 10.4155/tde⁃2017⁃0058.
［3］	Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis［J］. J Am Acad Dermatol, 2006,54（3 Suppl 2）:S67⁃S80. doi: 10.1016/j.jaad.2005.10.057.
［4］	Cheuk S, Wikén M, Blomqvist L, et al. Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis［J］. J Immunol, 2014,192（7）:3111⁃3120. doi: 10.4049/jimmunol.1302313.
［5］	Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome［J］. Science, 2009,324（5931）:1190⁃1192. doi: 10.1126/science.1171700.
［6］	Harmsen HJ, de Goffau MC. The human gut microbiota［J］. Adv Exp Med Biol, 2016,902:95⁃108. doi: 10.1007/978⁃3⁃319⁃31248⁃4_7.
［7］	Mayer EA. Gut feelings: the emerging biology of gut⁃brain communication［J］. Nat Rev Neurosci, 2011,12（8）:453⁃466. doi: 10.1038/nrn3071.
［8］	Petra AI, Panagiotidou S, Hatziagelaki E, et al. Gut⁃microbiota⁃brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation［J］. Clin Ther, 2015,37（5）:984⁃995. doi: 10.1016/j.clinthera.2015.04.002.
［9］	Jacobs JP, Braun J. Immune and genetic gardening of the intestinal microbiome［J］. FEBS Lett, 2014,588（22）:4102⁃4111. doi: 10. 1016/j.febslet.2014.02.052.
［10］	Ley RE, Hamady M, Lozupone C, et al. Evolution of mammals and their gut microbes［J］. Science, 2008,320（5883）:1647⁃1651. doi: 10.1126/science.1155725.
［11］	Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases［J］. BMC Immunol, 2017,18（1）:2. doi: 10.1186/s12865⁃016⁃0187⁃3.
［12］	Baker BS, Powles A, Fry L. Peptidoglycan: a major aetiological factor for psoriasis?［J］. Trends Immunol, 2006,27（12）:545⁃551. doi: 10.1016/j.it.2006.10.001.
［13］	Fry L, Baker BS, Powles AV, et al. Is chronic plaque psoriasis triggered by microbiota in the skin?［J］. Br J Dermatol, 2013,169（1）:47⁃52. doi: 10.1111/bjd.12322.
［14］	Yamasaki K, Di NA, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea［J］. Nat Med, 2007,13（8）:975⁃980. doi: 10.1038/nm1616.
［15］	Morizane S, Gallo RL. Antimicrobial peptides in the pathogenesis of psoriasis［J］. J Dermatol, 2012,39（3）:225⁃230. doi: 10.1111/j. 1346⁃8138.2011.01483.x.
［16］	Wang F, Zhang X, Xia P, et al. Enhancement of mRNA of survivin and human beta⁃defensin⁃3 in lesions of psoriasis vulgaris［J］. Eur J Dermatol, 2016,26（1）:28⁃33. doi: 10.1684/ejd. 2015.2698.
［17］	Jin T, Sun Z, Chen X, et al. Serum human beta⁃defensin⁃2 is a possible biomarker for monitoring response to JAK inhibitor in psoriasis patients［J］. Dermatology, 2017,233（2⁃3）:164⁃169. doi: 10.1159/000475809.
［18］	Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis［J］. N Engl J Med, 2002,347（15）:1151⁃1160. doi: 10.1056/NEJMoa021481.
［19］	Gao Z, Tseng CH, Strober BE, et al. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions［J/OL］. PLoS One, 2008,3（7）:e2719. doi: 10.1371/journal.pone.0002719.
［20］	Zanvit P, Konkel JE, Jiao X, et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis［J］. Nat Commun, 2015,6:8424. doi: 10.1038/ncomms9424.
［21］	Rudramurthy SM, Honnavar P, Chakrabarti A, et al. Association of Malassezia species with psoriatic lesions［J］. Mycoses, 2014,57（8）:483⁃488. doi: 10.1111/myc.12186.
［22］	Pietrzak A, Grywalska E, Socha M, et al. Prevalence and possible role of Candida Species in patients with psoriasis: a systematic review and meta⁃analysis［J/OL］. Mediators Inflamm, 2018,2018:9602362. doi: 10.1155/2018/9602362.
［23］	Fry L, Baker BS, Powles AV, et al. Psoriasis is not an autoimmune disease?［J］. Exp Dermatol, 2015,24（4）:241⁃244. doi: 10.1111/exd.12572.
［24］	Kim J, Krueger JG. The immunopathogenesis of psoriasis［J］. Dermatol Clin, 2015,33（1）:13⁃23. doi: 10.1016/j.det.2014.09.002.
［25］	Mahdavinia M, Rasmussen HE, Engen P, et al. Atopic dermatitis and food sensitization in South African toddlers: role of fiber and gut microbiota［J］. Ann Allergy Asthma Immunol, 2017,118（6）:742⁃743.e3. doi: 10.1016/j.anai.2017.04.011.
［26］	Chan CW, Wong RS, Law PT, et al. Environmental factors associated with altered gut microbiota in children with eczema: a systematic review［J］. Int J Mol Sci, 2016,17（7）:1147. doi: 10. 3390/ijms17071147.
［27］	Krueger JG. Hiding under the skin: a welcome surprise in psoriasis［J］. Nat Med, 2012,18（12）:1750⁃1751. doi: 10.1038/nm.3025.
［28］	Eppinga H, Sperna WCJ, Thio HB, et al. Similar depletion of protective faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa［J］. J Crohns Colitis, 2016,10（9）:1067⁃1075. doi: 10.1093/ecco⁃jcc/jjw070.
［29］	Scher JU, Ubeda C, Artacho A, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease［J］. Arthritis Rheumatol, 2015,67（1）:128⁃139. doi: 10.1002/art.38892.

[1]	高萌杨仙鸿姜祎群. 人工智能在医学领域的研究进展[J]. 中华皮肤科杂志, 2019, 52(2): 131-134.
[2]	胡宇晴张建中. 特应性皮炎治疗药物研究进展[J]. 中华皮肤科杂志, 2019, 52(1): 57-60.
[3]	刘念陈宏翔. 人工智能在皮肤科领域的应用与发展[J]. 中华皮肤科杂志, 2019, 52(1): 63-66.
[4]	郑林石臻睿何敏彤谭国珍. 奥马珠单抗治疗慢性自发性荨麻疹的进展[J]. 中华皮肤科杂志, 2019, 52(1): 60-63.
[5]	余艺昕杨斌. 手湿疹中外诊疗指南概述[J]. 中华皮肤科杂志, 2019, 52(1): 53-56.
[6]	李中明周南杜旭峰许文嵘王磊孙杰杨军范卫新. 头皮病理活检在脱发疾病诊疗中的相关应用[J]. 中华皮肤科杂志, 2019, 52(1): 67-70.